Related Experiment Videos
Trisomy 3 in cold agglutinin disease
J Gordon1, L Silberstein, L Moreau
1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-6082.
Cancer Genetics and Cytogenetics
|May 1, 1990
Summary
Chromosomal abnormalities, specifically trisomy 3, were found in some patients with cold agglutinin disease (CAD). This suggests a potential link between these genetic changes and the progression of CAD to lymphoma.
Area of Science:
- Hematology
- Immunology
- Genetics
Background:
- Cold agglutinin disease (CAD) is an autoimmune hemolytic anemia.
- It is typically associated with clonal expansion of B lymphocytes producing antibodies.
Purpose of the Study:
- To investigate chromosomal abnormalities in patients with CAD.
- To explore the potential link between these abnormalities and disease progression.
Main Methods:
- Karyotypic analysis of peripheral blood was performed on 16 patients with CAD.
- Patients were monitored for the development of lymphoma.
Main Results:
- Six out of 16 patients with CAD showed a chromosomally abnormal clone in their peripheral blood.
- Trisomy 3 was observed in four patients, trisomy 12 in one, and both in three.
- Two patients with chromosomal abnormalities were later diagnosed with lymphoma, while none without abnormalities developed lymphoma.
Conclusions:
- Trisomy 3 may provide a growth advantage to B-cell lineage, particularly in later differentiation stages.
- The identified clone in CAD patients could potentially progress to clinical lymphoma.